Trials / NCT01068561
Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa
Completed Phase 1 Cell therapy
- Sponsor
- University of Sao Paulo
- Treatment
- intravitreal injection of autologous bone marrow stem cells
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to no upper limit
- Enrollment
- 5 participants
- Started
- 2009-05
- Main results expected
- 2010-01
- Results posted
- Not yet
- Record last updated
- 2011-09-20
What the study is testing
The purpose of this study is to evaluate the short-term safety of a single intravitreal injection of autologous bone marrow stem cells in patients with retinitis pigmentosa.
Where it runs
Brazil (1)
- CPRS, São Jose Do Rio Preto, São Paulo